Jacob Chacko's Net Worth
$10.5 Million
Who is Jacob Chacko?
Jacob Chacko has an estimated net worth of $10.5 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., 4D Molecular Therapeutics, Inc., Ignyta, Inc., and Oric Pharmaceuticals, Inc..
SEC CIK
Jacob Chacko's CIK is 0001608936
Past Insider Trading and Trends
2022 was Jacob Chacko's most active year for acquiring shares with 13 total transactions. Jacob Chacko's most active month to acquire stocks was the month of April. 2021 was Jacob Chacko's most active year for disposing of shares, totalling 20 transactions. Jacob Chacko's most active month to dispose stocks was the month of April. 2022 saw Jacob Chacko paying a total of $3,012,305.05 for 2,206,666 shares, this is the most they've acquired in one year. In 2018 Jacob Chacko cashed out on 395,772 shares for a total of $1,905,444.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Turning Point Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
4D Molecular Therapeutics, Inc. (FDMT) Snapshot price: $28.421
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
$14.73 | -$53,219.50 |
0
|
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ignyta, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -70.57K |
$27.00 | -$1,905,444.00 |
0
|
Feb 8
| |||
Form 4
| +6.65% | 4.4K |
—
|
—
| 70.57K |
Jan 5
| |||
Form 4
| +54.47% | 23.33K |
—
|
—
| 66.17K |
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +30.45% | 10K |
$5.64 | $56,350.00 | 42.84K |
Mar 17
| |||
Form 4
| +410.07% | 26.4K |
—
|
—
| 32.84K |
Jan 7
| |||
Form 4
| +30.38% | 1.5K |
$12.00 | $18,000.00 | 6.44K |
Dec 16
| |||
Form 4/A
| +43.63% | 1.5K |
$12.40 | $18,600.00 | 4.94K |
Aug 20
| |||
Form 4
| +43.63% | 1.5K |
$12.40 | $18,600.00 | 4.94K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
| +86.85% | 1.6K |
$6.46 | $10,320.20 | 3.44K |
Nov 21 - Nov 24
| |||
Form 4
|
∞
| 1.84K |
$7.53 | $13,846.20 | 1.84K |
Aug 15 - Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oric Pharmaceuticals, Inc. (ORIC) Snapshot price: $12.63
PRESIDENT AND CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.20% | -40.00K |
$16.21 | -$648,380.00 | 728.54K |
Mar 6
| |||
Form 4
| -4.95% | -40.00K |
$12.23 | -$489,346.18 | 768.54K |
Feb 6 - Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +3.08% | 24.13K |
$8.58 | -$124,812.95 | 808.54K |
Dec 15
| |||
Form 4
| -1.97% | -15.66K |
$8.01 | -$125,499.35 | 780.65K |
Jul 10 - Jul 11
| |||
Form 4
| -0.54% | -4.34K |
$8.01 | -$34,710.55 | 796.32K |
Jul 5
| |||
Form 4
| -2.44% | -20.00K |
$8.03 | -$160,562.00 | 800.65K |
Jun 26
| |||
Form 4/A
| -0.75% | -6.14K |
$3.07 | -$18,859.00 | 816.65K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +1.35% | 10.9K |
$3.25 | -$18,733.00 | 817.02K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
| +127.60% | 450K |
$2.86 | $1,288,597.14 | 802.65K |
May 11 - May 13
| |||
Form 4
| +13,197.59% | 350K |
$4.92 | $1,723,707.92 | 352.65K |
Mar 23 - Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| -75.46% | -8.16K |
$25.05 | -$204,335.06 | 2.65K |
Scheduled
|
Sep 14 - Sep 15
| ||
Form 4
| -34.70% | -5.74K |
$25.05 | -$143,872.16 | 10.81K |
Scheduled
|
Sep 10 - Sep 13
| ||
Form 4
| -27.19% | -6.18K |
$25.11 | -$155,180.34 | 16.55K |
Scheduled
|
Sep 7 - Sep 8
| ||
Form 4
| -1.73% | -400.00 |
$25.07 | -$10,028.00 | 22.73K |
Scheduled
|
May 27
| ||
Form 4
| -23.91% | -7.27K |
$25.15 | -$182,851.76 | 23.13K |
Scheduled
|
May 20 - May 24
| ||
Form 4
| -47.74% | -27.78K |
$25.34 | -$703,982.97 | 30.4K |
Scheduled
|
May 14 - May 18
| ||
Form 4
| -3.68% | -2.22K |
$25.13 | -$55,780.21 | 58.18K |
Scheduled
|
May 11 - May 13
| ||
Form 4
| -2.11% | -1.30K |
$25.14 | -$32,684.70 | 60.4K |
Scheduled
|
Apr 28 - Apr 30
| ||
Form 4
| -1.28% | -800.00 |
$25.09 | -$20,069.60 | 61.7K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
∞
| 62.5K |
—
|
—
| 62.5K |
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||